Exercise and Compression for Lymphedema
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-08-26
- Last Posted Date
- 2023-10-02
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 40
- Registration Number
- NCT05022823
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 128
- Registration Number
- NCT04990895
- Locations
- 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-07-07
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 31
- Registration Number
- NCT04952480
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
iTTo for Treatment Naive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2021-03-22
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 7
- Registration Number
- NCT04808791
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
Tamoxifen Versus Etoposide After First Recurrence in GBM Patients
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 60
- Registration Number
- NCT04765098
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
mHealth Physical Activity Intervention for Young Cancer Survivors
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 320
- Registration Number
- NCT04765241
- Locations
- 🇨🇦
Holy Cross Centre, Calgary, Alberta, Canada
Chemoradiotherapy Versus Biomarker-Guided Therapy for Elderly and Frail GBM Patients
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-01-30
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 121
- Registration Number
- NCT04765514
- Locations
- 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦Cross Cancer Institute, Edmonton, Alberta, Canada
Study of Niacin in Glioblastoma
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-12-21
- Last Posted Date
- 2023-10-16
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 59
- Registration Number
- NCT04677049
- Locations
- 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Pre- Versus Post-operative SRS for Resectable Brain Metastases
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-07-17
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 88
- Registration Number
- NCT04474925
- Locations
- 🇨🇦
Tom Baker Cancer Centre/Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
🇨🇦Cross Cancer Institute, Edmonton, Alberta, Canada
Accelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain Metastases
- First Posted Date
- 2020-07-08
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 20
- Registration Number
- NCT04461418
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
© Copyright 2024. All Rights Reserved by MedPath